CLINICAL_TRIALS
trial_result
· 2024-03-12
Clinical Trial Update: A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years [Phase 4]
Summary
Phase 4 results from a study evaluating the effectiveness of empagliflozin in Japanese adults aged over 65 with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2024-03-12